— Know what they know.
Not Investment Advice
Also trades as: ACON (NASDAQ) · $vol 0M

ACONW NASDAQ

Aclarion, Inc.
1W: +16.7% 1M: -5.4% 3M: +12.4% YTD: -19.8% 1Y: -33.6% 3Y: -80.7%
$0.03
+0.00 (+0.67%)
 
Weekly Expected Move ±64.4%
$-0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 34 · $15999 mcap · 533279 float · 4.95% daily turnover · Short 80% of daily vol
Smart Money Score
Watch 25
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.0M
52W Range0.02-0.2333
Volume100
Avg Volume26,376
Beta1.21
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBrent Ness
Employees11
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2022-04-22
8181 Arista Place
Broomfield, CA 80021
US
650-241-1741
About Aclarion, Inc.

Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.

Recent Insider Trades

NameTypeSharesPriceDate
Neal David K P-Purchase 2,500 $3.10 2026-05-11
Wesemann William P-Purchase 1,562 $3.30 2026-05-06
Gould Gregory A 0 — 2025-09-02
Wesemann William A-Award 63,000 — 2022-12-29
Neal David K J-Other 152,128 — 2022-12-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms